To assess the current use of glucocorticoids (GCs) in Duchenne muscular dystrophy in the UK, and compare the benefits and the adverse events of daily versus intermittent prednisolone regimens.
Publication
Journal of neurology, neurosurgery, and psychiatry, 2013, Vol 84, Issue 6, p698